New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 4, 2014
10:01 EDTDWA, DSPG, PG, INFI, TIVO, TEN, MNST, FTNT, AAP, SC, LADR, CL, CLX, ARGS, ENR, KO, CHD, EL, DPS, CCE, AVP, GTATOn The Fly: Analyst Initiation Summary
Argos Therapeutics (ARGS) initiated with an Overweight at Piper Jaffray... Avon Products (AVP) initiated with a Sell at UBS... Church & Dwight (CHD) initiated with a Buy at UBS... Clorox (CLX) initiated with a Sell at UBS... Coca-Cola Enterprises (CCE) initiated with a Neutral at UBS... Coca-Cola (KO) initiated with a Neutral at UBS... Colgate-Palmolive (CL) initiated with a Buy at UBS Dr Pepper Snapple (DPS) initiated with a Neutral at UBS... Energizer (ENR) initiated with a Sell at UBS... Estee Lauder (EL) initiated with a Buy at UBS... GT Advanced (GTAT) initiated with a Buy at Goldman... Infinity Pharmaceuticals (INFI) initiated with an Underperform at Wedbush... Ladder Capital (LADR) initiated with an Outperform at Keefe Bruyette... Monster Beverage (MNST) initiated with a Buy at UBS... Procter & Gamble (PG) initiated with a Neutral at UBS... Santander Consumer USA (SC) initiated with an Outperform at Wells Fargo... Tenneco (TEN) initiated with a Buy at UBS... DSP Group (DSPG) initiated with a Buy at Dougherty... Advance Auto Parts (AAP) initiated with an Equal Weight at Stephens... TiVo (TIVO) initiated with a Buy at Topeka... DreamWorks Animation (DWA) initiated with a Hold at Topeka... Fortinet (FTNT) coverage assumed with an Outperform at Wedbush.
News For ARGS;AVP;CHD;CLX;CCE;KO;CL;DPS;ENR;GTAT;EL;INFI;LADR;MNST;PG;SC;TEN;DSPG;AAP;TIVO;DWA;FTNT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
July 22, 2015
07:34 EDTKOCoca-Cola sees currency to be 7 point headwind to Q3 revenue
For Q3, Coca-Cola estimates that currency will be an approximate 7 point headwind on net revenues, a 13 point headwind on operating income and a 10 point headwind on income before taxes.
07:34 EDTKOCoca-Cola backs comparable currency neutral growth expectations
Coca-Cola estimates that the net impact of structural items on FY15 results will be a 1 point headwind on both net revenues and income before taxes. The company expects fluctuations in foreign currency exchange rates to have an unfavorable impact on its reported results in 2015. Based on current spot rates, its existing hedge positions, and the cycling of its prior year rates, Coke estimates that currency will be an approximate 6 point headwind on net revenues, an 11 point headwind on operating income, and a 7 to 8 point headwind on income before taxes for the full year.
07:32 EDTKOCoca-Cola reports Q2 comparable EPS 63c, consensus 60c
Subscribe for More Information
July 21, 2015
16:22 EDTLADRLadder Capital files to sell 2.36M shares of Class A common stock for holders
15:22 EDTKOCoca-Cola technical comments ahead of results
Subscribe for More Information
15:02 EDTKONotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's open, with earnings consensus, include Coca-Cola (KO), consensus 60c... Boeing (BA), consensus $1.42... Abbott Laboratories (ABT), consensus 50c... Thermo Fisher Scientific (TMO), consensus $1.78... EMC (EMC), consensus 41c... Illinois Tool Works (ITW), consensus $1.28... St. Jude Medical (STJ), consensus $1.00... Northern Trust (NTRS), consensus 96c... Check Point Software (CHKP), consensus 95c... Polaris Industries (PII), consensus $1.58... Interpublic Group (IPG), consensus 27c... New York Community Bancorp (NYCB), consensus 26c... B/E Aerospace (BEAV), consensus 76c... Owens Corning (OC), consensus 54c... Knight Transportation (KNX), consensus 37c.
12:25 EDTKOCoca-Cola July weekly volatility elevated into Q2 and outlook
Subscribe for More Information
10:01 EDTPG, MNST, EL, CL, DPS, KO, CLX, AVP, CHDOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:36 EDTARGSArgos Therapeutics announces formation of Scientific Advisory Board
Argos Therapeutics announced the formation of the company's first Scientific Advisory Board. Jeff Abbey, president and CEO of Argos, stated, "Forming a scientific advisory board is another important step as we continue to build Argos into a fully-integrated, commercial immuno-oncology company. These oncology and immunology experts will provide us with guidance on many clinical and technical aspects of our development programs. Their input is especially welcome as we continue our pivotal phase 3 ADAPT clinical trial of our lead product candidate, AGS-003, for the treatment of metastatic renal cell carcinoma, and as we plan to begin testing AGS-003 in other tumor types."
July 20, 2015
16:46 EDTCHDChurch & Dwight initiated with a Neutral at Sterne Agee CRT
16:45 EDTKOCoca-Cola initiated with a Buy at Sterne Agee CRT
Target $46.
16:45 EDTDPSDr Pepper Snapple initiated with a Buy at Sterne Agee CRT
Subscribe for More Information
16:39 EDTELEstee Lauder initiated with a Buy at Sterne Agee CRT
Subscribe for More Information
16:39 EDTCLXClorox initiated with a Buy at Sterne Agee CRT
Subscribe for More Information
16:36 EDTPGProcter & Gamble initiated with a Neutral at Sterne Agee CRT
Subscribe for More Information
16:36 EDTAVPAvon Products initiated with a Neutral at Sterne Agee CRT
Subscribe for More Information
16:35 EDTCLColgate-Palmolive initiated with a Buy at Sterne Agee CRT
Subscribe for More Information
16:11 EDTMNSTMonster Beverage initiated with a Buy at Sterne Agee CRT
Subscribe for More Information
July 19, 2015
13:37 EDTPGProcter & Gamble shares look unattractive, Barron's says
Subscribe for More Information
13:20 EDTENR'More gains could be ahead' for Energizer shares, Barron's says
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use